Intelligent 2D™ Synthesised Imaging
Reveal more details in high-resolution 3D Mammography™ exams.
Make Fast, Confident Decisions
While 3D Mammography exams offer superior clinical performance compared to 2D alone,1-4 some radiologists want more: higher image quality, more detail, improved read times and low dose.
Powered by AI, Intelligent 2D imaging technology produces robust, yet natural looking, synthesised 2D images that are well correlated with the 3D mammography data. This enables radiologists to quickly and confidently see subtle mammography features and lesion morphology.*
Retain More Features of Interest
See Clearer for an Easier Diagnosis
Retain more features of interest from high-resolution 3D mammography data. Use AI-powered analytics to confidently visualise subtle tissue features and lesions in the reconstructed, synthesised 2D images.
Save Exam Time, Reduce Dose
Intelligent 2D eliminates the need for additional conventional 2D exposure and reduces scan time by about 50%, expediting the exam workflow and improving patient comfort.5
Streamline Reading Workflow
Expedite 3D Mammography exam read times with Intelligent 2D’s built-in mapping capability, compared to 2D.
Unlock the Advantage of Time
The Breast Health Continuum of Care offers integrated solutions for clinical confidence, workflow efficiency and compassionate patient care. It gives more women more time in better health.
Intelligent 2D Synthesised Imaging is part of the Hologic Screening and Diagnosis Solution.
Retain More Features of Interest
- Exceptional 2D image contrast, sharp images with enhanced background and localised density appearance to enable FFDM-like representation of parenchymal tissue at 70μm resolution.
- Move from suspicious areas detected on the 2D image to the point of interest on the 3D mammography slice.
- Lower dose as a new image is generated using machine-learning algorithms and high-resolution 3D mammography data for a robust, natural-looking image.
- 3.7 second scans reduce compression time, minimise motion and improve patient comfort.
Visit Our Virtual Hospital
Browse our portfolio of Breast Health solutions in 3D. See how you can unlock the advantage of time across the entire Breast Continuum of Care.
Hologic AI-powered Integrated Software Solutions
Our products are designed to work together and can be customised to your needs. Discuss your clinical needs with our experienced team to find the best solution that suits you. Browse the relevant options below.
Hologic Integrated Breast Health AI Software Suite
Discover the Hologic suite of integrated, future proofed AI solutions, to improve early detection and diagnosis of breast cancer, help to accelerate workflow, and enable personalised patient care, with automated breast density assessment.
Accelerated AI-powered Cancer Detection Solution
The optimal AI combination of technologies for efficient cancer detection and accelerated reading workflow, aiding radiologists in early detection and diagnosis of breast cancer.
Evidence. Insight. Collaboration.
Our education portal improves patient care through excellence in education, communication of clinical and scientific evidence, and partnerships with the healthcare community.
Insights
*Intelligent 2D™ synthesised imaging is a purchasable option with Hologic 3D Mammography exams.
-
Friedewald SM, Rafferty EA, Rose SL, et al. Breast cancer screening using tomosynthesis in combination with digital mammography. JAMA. 2014 Jun 25;311(24):2499-507. Breast cancer screening using tomosynthesis in combination with digital mammography."" JAMA 311.24 (2014): 2499-2507; a multi-site (13), non-randomized, historical control study of 454,000 screening mammograms investigating the initial impact the introduction of the Hologic Selenia® Dimensions ® on screening outcomes. Individual results may vary. The study found an average 41% (95% CI: 20-65%) increase and that 1.2 (95% CI: 0.8-1.6) additional invasive breast cancers per 1000 screening exams were found in women receiving combined 2D FFDM and 3D™ mammograms acquired with the Hologic 3D Mammography™ System versus women receiving 2D FFDM mammograms only
-
Bernardi D, Macaskill P, Pellegrini M, et. al. Breast cancer screening with tomosynthesis (3D mammography) with acquired or synthetic 2D mammography compared with 2D mammography alone (STORM-2): a population-based prospective study. Lancet Oncol. 2016 Aug;17(8):1105-13.
-
Zuckerman SP, Conant EF, Keller BM, et al. Implementation of Synthesized Two-dimensional Mammography in a Population-based Digital Breast Tomosynthesis Screening Program. Radiology. 2016 Dec;281(3):730-736
-
Skaane P, Bandos A, Eben EB, et al. Two-view digital breast tomosynthesis screening with synthetically reconstructed projection images: comparison with digital breast tomosynthesis with full-field digital mammographic images. Radiology. 2014 Jun;271(3):655-63.
-
Abdullah P, Alabousi M, Ramadan S et al, Synthetic 2D Mammography Versus Standard 2D Digital Mammography: A Diagnostic Test Accuracy Systematic Review and Meta-Analysis, Am. Journal of Roentgenology. 2021;217: 314-325. 10.2214/AJR.20.24204
Documents
Safety Data Sheets
Package Inserts
2797
Hologic BV, Da Vincilaan 5, 1930 Zaventem, Belgium.
Notified Body number wherever applicable
EC Representative Information wherever applicable